Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06152627 · ClinicalTrials.gov registry record

Voice Therapy Per the Rehabilitation Treatment Specification System

A clinical trial of Muscle Tension Dysphonia, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
600
Enrollment target
5
Study locations

NCT06152627 is a study of Muscle Tension Dysphonia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 600 participants, above the 145-participant average among 4 other Muscle Tension Dysphonia trials with a reported enrollment target (314% higher). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06152627, a study of Muscle Tension Dysphonia, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
600 participants
Enrollment target
5
Study locations

Study Summary

The goal of this study is to evaluate if using evidence-based, standard ingredient and target codes from the Rehabilitation Treatment Specification System - Voice Therapy (RTSS-Voice) in standard of care voice therapy documentation can improve outcomes for patients with muscle tension dysphonia (MTD). The main question it aims to answer is: Since the RTSS-Voice will help clinicians think about their treatment more specifically and in relation to nine evidence-based therapies, will its adoption be associated with improved outcomes? Clinicians across five voice centers will be asked to use the RTSS-Voice to document their voice therapy sessions for patients with MTD. Researchers will compare changes in outcomes between two groups of patients: those treated during the clinician's first year using the RTSS-Voice versus those treated during the clinician's second year using the RTSS-Voice.

Conditions Studied

Interventions

  • BEHAVIORAL Standard of care voice therapy with novice clinician RTSS-Voice documentation
  • BEHAVIORAL Standard of care voice therapy with expert clinician RTSS-Voice documentation

Study Locations (5)

Georgia

  • Emory University - Atlanta

Massachusetts

  • Massachusetts General Hospital - Boston

New York

  • New York University - New York

Utah

  • University of Utah - Salt Lake City

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2026-02-03
Est. Completion 2027-06-29

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06152627

The ClinicalTrials.gov registry entry for NCT06152627 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 145-participant average among 4 other Muscle Tension Dysphonia trials with a reported enrollment target (314% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Muscle Tension Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which Standard of care voice therapy with novice clinician RTSS-Voice documentation is the first listed.

NCT06152627 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Georgia, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT06152627 about?

NCT06152627 is a clinical study titled "Voice Therapy Per the Rehabilitation Treatment Specification System". The goal of this study is to evaluate if using evidence-based, standard ingredient and target codes from the Rehabilitation Treatment Specification System - Voice Therapy (RTSS-Voice) in standard of care voice therapy documentation can improve outcomes for patients with muscle tension dysphonia (MTD...

What is the current status of trial NCT06152627?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2026-02-03. Estimated completion is 2027-06-29.

What conditions does trial NCT06152627 study?

This clinical trial studies the following conditions: Muscle Tension Dysphonia.

What interventions are being tested in trial NCT06152627?

The interventions under investigation include: Standard of care voice therapy with novice clinician RTSS-Voice documentation (BEHAVIORAL), Standard of care voice therapy with expert clinician RTSS-Voice documentation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06152627?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06152627 being conducted?

This trial has 5 study locations across Georgia, Massachusetts, New York, Utah, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Muscle Tension Dysphonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.